In this role, Paul will lead the company’s global commercial strategy, drive business development initiatives, and play a pivotal role in fostering strategic partnerships. Paul Orange brings with him a wealth of experience in the bioprocessing industry, having held key leadership positions in various companies. His strategic vision, deep industry knowledge, and proven track record […]

CARLSBAD, Calif.  Image:               Overview:         To help labs pursue more sustainable practices, Thermo Fisher Scientific has launched a next generation Invitrogen™ TaqMan™ Cells-to-CT™ Express Kit*, offering simplified, scalable workflows for gene expression analysis that produce less plastic waste. With improved chemistry, the Cells-to-CT Express Kit helps […]

Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived Organ-on-a-Chip solution for more accurate in vitro ADME predictions   Early access to dual-organ model available through CN Bio’s Contract Research Services  Cambridge, UK, and Durham, North Carolina, US: CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy […]

Funding will accelerate commercialization of the Singulator platform which enables single cell or nuclei suspensions from solid tissues LIVERMORE, Calif. — S2 Genomics, the leading manufacturer of tissue sample preparation systems for single cell genomics assays, announced today that it has raised $16 million in Series A funding from BroadOak Capital Partners and Research Corporation […]

Companies to automate a critical step of high-throughput single-cell multiomics experiments FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and […]

LOS ANGELES — Calibre Scientific is pleased to announce the acquisition of RUWAG Handels AG (“RUWAG” or the “Company”), a provider of diagnostics and life sciences products and services, selling to hospitals, private labs, universities and pharmaceutical companies in Switzerland. This strategic acquisition highlights Calibre Scientific’s dedication to broadening its range of products and services […]

VANCOUVER, British Columbia — STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine. “The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada’s biotechnology industry,” said Dr. Allen […]

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing CARLSBAD, Calif. — To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the launch of the Gibco™ Cell Therapy Systems (CTS™) Cellmation™ Software, a first-of-its-kind automation solution designed to […]

CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round. The company aims to enable the cost-effective, reliable, and rapid development of new cell therapies. Stem cells unlock a range of treatment possibilities that have not previously been available to […]

AcouSort’s collaboration with the global life science company has reached yet another significant milestone with the signing of a Statement of Work (SoW) describing Phase 3 in the ongoing collaboration. The new assignment will generate revenues of at least SEK 485,000 in 2024. The collaboration, which began in 2022, aims to demonstrate how AcouSort’s AcouWash […]